Is it safe?
Can PAHC take a bad year?
Phibro Animal Health Corporation carries $543M of net debt at 2.36× EBITDA: a load its earnings can carry.
$543M
Net debt · as at Q3 2026 · under two and a half years of EBITDA, comfortable
- Net debt / EBITDA
- 2.36×
Net debt / EBITDA · 4.11× a year ago · the load is coming down
- Altman Z-score
- 2.68
Altman Z-score · grey zone, between 1.8 and 3
- Interest cover
- 4.02×
Interest cover · operating profit covers the interest bill, with room to spare
Details›
- Total debtQ3 2026
- $621M
- Cash and short-term investments
- $77M
- Net debt
- $543M
- EBITDA, trailing twelve months
- $231M
- Operating profit, trailing twelve months
- $180M
- Debt / equity
- 1.72×
- Total debt / EBITDA
- 2.69×
- Annualised volatilitytwo years of daily moves
- 53%
- Worst drawdown on file
- −80%
- Below its 52-week high
- −39%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.
Drug Manufacturers - Specialty & Generic
Ranks #11 of 28 by Smart Score